Synchronous occurrence of papillary thyroid carcinoma and solitary fibrous tumor of the thyroid: a case report Authors: Maissa Ben Thayer, Imen Helal, Raoueh Hedhli, Emna Rejeb, Fatma Khanchel, Ehsen Ben Brahim, Raja Jouini, Aschraf Chadli-Debbiche Published: 2024 ABSTRACT BackgroundSolitary fibrous tumors (SFT) are ubiquitous mesenchymal neoplasms of intermediate malignant potential. SFTs of the head and neck are rare, representing less than 0.1% of all SFTs. Solitary fibrous tumors of the thyroid (SFTT) are even rarer. Only 49 cases of SFTTs have been documented in the literature, with just two cases being synchronous with papillary thyroid carcinoma (PTC). By presenting a synchronous PTC and SFTT case, we aim to review the clinical presentation, diagnostic challenges, histopathological characteristics, and management strategies associated with this unusual co-occurrence.Case presentationA 46-year-old North African female patient with no prior medical history presented with a year-long, indwelling cervical swelling. Cervical ultrasound revealed two nodules in the right thyroid lobe and one nodule in the left thyroid lobe. The first right thyroid nodule, measuring 50 mm, is classified as European Thyroid Imaging and Reporting Data System (EU-TIRADS) III. The second right thyroid nodule, measuring 15 mm, and the 25 mm left thyroid nodule were classified as EU-TIRADS IV. A total thyroidectomy with bilateral lymphadenectomy was performed. Microscopic examination revealed that the left nodule and right nodule measuring 15 mm corresponded to invasive PTCs. The second nodule in the right lobe corresponded to a proliferation of spindle cells arranged in sheets and wavy or storiform bundles with a hemangiopericytoma-like vascular pattern. The spindle cells had indistinct boundaries with elongated non-atypical nuclei. There was no mitosis. On immunochemistry, the spindle cells showed strong and diffuse positivity for CD34 and CD99. They are negative for smooth muscle actin, S100, and cytokeratin. It was then confirmed to be an SFTT case. The final diagnosis was of synchronous PTC and SFTT.ConclusionWe presented the third case of synchronous PTC and SFTT. The co-occurrence of these tumors is likely incidental. However, further studies are needed to assess the physiopathology and molecular alterations of this association. Background Papillary thyroid carcinoma (PTC) is the most prevalent histologic subtype of thyroid cancer, representing 80–90% of all cases [1]. It may coexist with other epithelial thyroid neoplasms, either benign or malignant. However, the simultaneous occurrence of PTC and a primary mesenchymal tumor is exceedingly rare [2]. Solitary fibrous tumors (SFT) are mesenchymal neoplasms of intermediate malignant potential, rarely occurring in the thyroid gland [3]. Only 49 cases of solitary fibrous tumors of the thyroid (SFTT) were documented in the literature, with just two cases being synchronous with PTC [4, 5]. By presenting a synchronous PTC and SFTT case, we aim to review the clinical presentation, diagnostic challenges, histopathological characteristics, and management strategies associated with this unusual co-occurrence. Case presentation A 46-year-old North African female patient with no prior medical history presented with a year-long, indwelling, progressively enlarging low cervical swelling. Physical examination revealed bilateral palpable thyroid nodules. Cervical ultrasound revealed two nodules in the right thyroid lobe and one nodule in the left thyroid lobe. The first right thyroid nodule, measuring 50 mm, was solid hypoechoic, and well demarked, and was classified as European Thyroid Imaging and Reporting Data System (EU-TIRADS) III. This nodule’s fine-needle aspiration (FNA) cytology was classified as Bethesda II, indicating a benign lesion. The second right thyroid nodule measured 15 mm, and the left was solid hypoechoic with irregular margins and microcalcifications; both were classified as EU-TIRADS IV. Cytology for the left nodule was classified as Bethesda VI, diagnostic for PTC. A total thyroidectomy with bilateral mediastinal-recurrent lymphadenectomy was performed. A gross examination of the thyroidectomy specimen revealed a 25 mm yellowish, granular, and shiny nodule in the lower left lobe. The right lobe contained a 55 mm solid, well-demarcated nodule, with a calcified upper nodule measuring 20 mm (Fig. 1). A frozen section examination of the left nodule was concluded to be a papillary carcinoma. Definitive histological examination after fixation revealed that the left nodule and the 20 mm right nodule corresponded to carcinomatous proliferations with papillary architecture. The cells were enlarged, with moderately abundant cytoplasm and large, irregular, vesicular, indented nuclei. The chromatin was dense and clumped, with small nucleoli and a thickened nuclear membrane (Fig. 2). These proliferations were surrounded by a fibrous capsule that was massively invaded, extending into the adjacent parenchyma. Vascular emboli were present. We concluded bifocal PTC. Bilateral lymph node metastases from PTC were identified. The 55 mm nodule in the right lobe corresponded to a proliferation of spindle cells arranged in sheets and wavy or storiform bundles. It was characterized by alternating hypocellular and hypercellular areas with a hemangiopericytoma-like vascular pattern. The spindle cells had indistinct boundaries with elongated, non-atypical nuclei. There was no mitosis (Fig. 3). On immunochemistry, the spindle cells showed strong and diffuse positivity for STAT6, CD34, and CD99. They are negative for smooth muscle actin, S100, and cytokeratin. It was then confirmed to be an SFTT case. The final diagnosis was of synchronous PTC and SFTT. The postoperative course was uneventful. The patient started to receive thyroid-stimulating hormone (TSH) suppression therapy. Radioactive iodine (RAI) therapy was indicated owing to the presence of PTC with lymph node metastases. At 9 months post-surgery, the patient showed no signs of distant metastases of either PTC or SFTT.Fig. 1Gross examination of the total thyroidectomy resection specimen: Co-occurrence of a solitary fibrous tumor (pink star), presenting as a well-circumscribed nodule with a fibrous tan cut surface and cystic spaces, and a papillary thyroid carcinoma (blue arrow), presenting as an ill-demarked white-yellowish calcified noduleFig. 2Microscopic examination of papillary thyroid carcinoma: A Carcinomatous proliferation with papillary architecture (hematoxylin–eosin, ×20). B The tumor cells were enlarged and atypical, with moderately abundant cytoplasm and large, irregular, vesicular, indented nuclei (hematoxylin–eosin, ×400)Fig. 3Microscopic examination of solitary fibrous tumor of the thyroid: A A mesenchymal proliferation made up of spindle cells arranged in sheets and storiform bundles entrapping thyroid follicles (hematoxylin–eosin, ×20); B hypercellular areas with a hemangiopericytoma-like vascular pattern (hematoxylin–eosin, ×100); and C spindle cells with indistinct boundaries and elongated, non-atypical nuclei (hematoxylin–eosin, ×400). D Immunohistochemical study: tumor cells show strong and diffuse positivity for STAT6 Gross examination of the total thyroidectomy resection specimen: Co-occurrence of a solitary fibrous tumor (pink star), presenting as a well-circumscribed nodule with a fibrous tan cut surface and cystic spaces, and a papillary thyroid carcinoma (blue arrow), presenting as an ill-demarked white-yellowish calcified nodule Microscopic examination of papillary thyroid carcinoma: A Carcinomatous proliferation with papillary architecture (hematoxylin–eosin, ×20). B The tumor cells were enlarged and atypical, with moderately abundant cytoplasm and large, irregular, vesicular, indented nuclei (hematoxylin–eosin, ×400) Microscopic examination of solitary fibrous tumor of the thyroid: A A mesenchymal proliferation made up of spindle cells arranged in sheets and storiform bundles entrapping thyroid follicles (hematoxylin–eosin, ×20); B hypercellular areas with a hemangiopericytoma-like vascular pattern (hematoxylin–eosin, ×100); and C spindle cells with indistinct boundaries and elongated, non-atypical nuclei (hematoxylin–eosin, ×400). D Immunohistochemical study: tumor cells show strong and diffuse positivity for STAT6 Discussion SFTs were first described in 1931 as a primary tumor of the pleura [6]. Since then, they have been reported in almost all anatomical sites [7]. Currently, extrapleural SFTs are the most common, accounting for approximately 70% of all cases [7]. SFTs of the head and neck are rare, representing less than 0.1% of all SFTs [8, 9]. SFTTs are exceptionally rare, with only 49 cases documented in the literature. Only two cases of synchronous PTC with SFTT were reported in the literature [4, 5]. In both cases, PTC was unifocal, and SFTT was in the contralateral thyroid lobe. There were no histological signs of malignancy for SFTTs in either case. The first case was that of a 70-year-old female patient [4]. The SFTT, which measured 1.7 cm, was found in the right lobe, while the PTC, measuring 2 cm, was in the left lobe. The second case involved a 78-year-old male patient [5]. The SFTT, located in the right lobe, measured 3.5 cm. The PTC, measuring 1 mm in the most significant dimension, was incidentally identified during the microscopic examination of systematic samples taken from the contralateral thyroid lobe. On the contrary, in our case, the SFTT was an unexpected finding during the workup of bilateral PTC. Although there are insufficient data regarding the pathophysiology of the co-occurrence of PTC and SFTT, the commonly accepted theory is that PTC and SFTT develop independently of one another. Because of the different histogenesis of the two neoplasms, the occurrence of both tumors in the same patient is likely to be coincidental [4]. PTC originates from the thyroid gland’s follicular cells, while SFTT arises from mesenchymal cells, which belong to a different cellular lineage. SFTT mainly develops in middle-aged adults, with an average age of 54.5 years [28–88] [10]. No cases of SFTT have been diagnosed in children or adolescents [10]. Similarly to SFTs of other anatomic sites, SFTTs do not exhibit sex predilection [11]. They usually present as a slow-growing cervical painless mass [11]. Symptoms resulting from the compression of adjacent organs, such as dyspnea, dysphagia, and dysphonia, are predominantly seen in large tumors [11, 12]. In half of the cases, the tumor exceeds 5 cm in size, with an average size of 5.8 cm [2–8, 8–13] [10]. In the case we present, the SFTT measured 5.5 cm. Diagnosing SFTT preoperatively can be difficult owing to its rarity and the nonspecific nature of its clinical and radiological features. Their prevalence is probably underestimated since small, slow-growing SFTTs lacking concerning imaging features are unlikely to be investigated further or may yield a non-diagnostic FNA [8]. Ultrasound typically identifies solid hypoechogenic well-demarcated nodules, occasionally with cystic echoic areas [3–5, 9]. Preoperative SFTT diagnosis using FNA is challenging, as the aspirates are often non-diagnostic due to low cellularity [11]. In a few cases, unicellular smears may show naked nuclei or some dyshesive spindle cells set in a background of amorphous eosinophilic collagenized material [13]. Cytological examination suggested the diagnosis in only three cases among the cases reported in the literature [3]. Immunohistochemical analysis using the anti-CD34 antibody on FNA cytoblock preparation samples provides an additional rationale for the diagnostic process [3]. In our case, FNA cytology was benign and showed no signs of SFTT. On gross examination, SFTT usually manifests as a well-circumscribed nodule with a fibrous white to tan cut surface [11, 14]. Cystic spaces and hemorrhages might be seen [9, 11]. On microscopic examination, SFTs are characterized by an alternance of hypocellular areas (keloid-like collagen) and hypercellular areas, with branching hemangiopericytoma-like vessels [15]. They comprise uniform spindle cells with scant cytoplasm, displaying a haphazard patternless, storiform, or desmoid-like arrangement [15]. The stroma is collagenous [11]. Normal thyroid follicles entrapped within the tumor are common and should not be considered an actual invasion of the adjacent thyroid parenchyma [9]. Instead, it represents a blending or merging of the components [11]. On immunohistochemical analysis, tumor cells are immunoreactive for CD34, CD99, BCL2, vimentine, and STAT6. They harm TTF1, thyroglobulin, calcitonin, cytokeratin, desmin, CD117, PS100, and neuroendocrine markers [15]. A gene fusion between NAB2 and STAT6 on chromosome 12q13 has been recognized as the pathognomonic molecular aberration in SFT [14, 16]. This NAB2–STAT6 fusion drives the nuclear translocation of STAT6, which can be detected immunohistochemically using an anti-STAT6 antibody [9]. Therefore, this antibody has substantially enhanced the diagnostic precision of SFT, serving as a highly sensitive and specific marker [3]. It is currently regarded as the most reliable tool for diagnosis [3]. Only solid and diffuse nuclear expression should be considered positive, as focal weak nuclear and cytoplasmic staining can sometimes occur in tumors other than SFT [11]. In our case, tumor cells showed diffuse and intense staining for STAT6. The diagnosis of SFTT can only be established after excluding other thyroid tumors exhibiting spindle cell morphology [10]. Distinguishing SFTT from other spindle cell tumors through morphology alone can be challenging [17]. Immunohistochemical analysis is the sole diagnostic tool to differentiate SFTT from other mimicking spindle cell lesions [9]. Epithelial neoplasms such as PTC, follicular adenoma, follicular carcinoma, and medullary carcinoma occasionally exhibit a spindled appearance, mimicking SFTT [9]. Spindle cells in these tumors are considered metaplastic, showing positivity for TTF-1, cytokeratin, and thyroglobulin, with no expression of STAT6 or CD34 [9]. PTC with fibromatosis-like stroma was the primary differential diagnosis to rule out in our case, given the presence of two other nodules corresponding to PTC. It consists of a variant of PTC featuring a prominent spindle cell component. Spindle cells are commonly arranged in interlacing fascicles within a collagenous matrix, which can give the tumor an appearance similar to an SFTT, especially when the epithelial component is inconspicuous [11]. In contrast to SFTT, the stromal component of PTC with desmoid-type fibromatosis shows positivity for smooth muscle actin and negativity for CD34 [11]. Medullary thyroid carcinoma may present a spindle cell component. However, unlike SFTT, these cells express keratin, calcitonin, and neuroendocrine markers [11]. Mesenchymal spindle cell tumors, including peripheral nerve sheath tumors (PNSTs), neurofibromas, schwannomas, leiomyomas, and leiomyosarcomas, though rare in the thyroid, should also be considered in the differential diagnosis [3, 10]. It is the immunohistochemical analysis that will enable an accurate diagnosis. Although most SFTTs are benign, histologic signs of malignancy might be seen in a few cases, and some histologic features of malignancy may be proposed, suggesting more aggressive behavior. In 1998, Vallat-Decouvelaere et al. proposed histologic features of malignancy suggesting a more aggressive behavior including: (i) high cellularity, (ii) cytological atypia, (iii) high mitotic count (> 4/10 HPF), and (iv) tumor necrosis or infiltrating margins [18]. The World Health Organization’s classification of tumors of endocrine organs identified pronounced cellular atypia and a high mitotic index as key histological indicators of malignancy of SFTTs. However, the clinical course of SFT is challenging to predict solely on the basis of histomorphological features [9]. Therefore, malignancy assessment is based on prediction models, with the modified Demicco score being the most validated [3]. It categorizes patients into three risk groups (low, intermediate, and high) on the basis of age (< 55 years or ≥ 55 years), tumor size (cm; < 5, 5–10, 10–15, or ≥ 15), mitotic count (per 10 high-power fields; 0, 1–3, or ≥ 4), and tumor necrosis (< 10% or ≥ 10%)[19]. In our case, the SFTT was classified as having a low risk of malignancy according to this score. A thyroid lobectomy may be sufficient for an isolated SFTT, provided there is no suspicion of malignancy, including the invasion of surrounding structures [14]. In the current case, apart from the SFTT, there were two nodules with preoperative cytology classified as Bethesda VI (CPT), prompting an immediate total thyroidectomy. TSH suppression therapy is not warranted in managing SFTT since the tumor cells are of stromal origin [14, 20]. The use of adjuvant chemotherapy or external radiation therapy, even for malignant tumors, is still debated [20, 21]. In our case, TSH suppression therapy was prescribed for synchronous PTC, while radioactive iodine (RAI) therapy was indicated owing to the presence of lymph node metastases from PTC. Most SFTTs have a favorable outcome [5]. Similar to SFTs in other locations, SFTTs require long-term clinical follow-up [11]. Among the 49 cases reported, only 2 showed evidence of recurrence and distant metastases [3, 20]. Both cases exhibited histologic signs of malignancy: increased cellularity, atypia, numerous mitoses, and tumor necrosis in the first case and increased cellularity with 16 mitoses per 10 high-power fields in the second case. The first patient developed local recurrence and bilateral lung metastases 5 months after surgery [20]. Adjuvant radiotherapy was recommended but declined by the patient [20]. The second patient presented with hepatic and lung metastases 12 and 14 months, respectively, postoperatively [3]—the hepatic metastasis was treated with cryoablation [3]. No treatment was provided for the pulmonary metastases [3]. In our case, no signs of distant metastasis were detected 9 months postoperatively. Conclusion SFTTs are exceedingly rare. However, they should always be considered in the differential diagnosis of thyroid spindle cell lesions. Although they usually have an indolent course, recurrence and distant metastasis might be seen exceptionally. Therefore, long-term clinical follow-up must be insured. We presented the third case of synchronous PTC and SFTT. The co-occurrence of these tumors is likely to be incidental. However, further studies are needed to assess the physiopathology and molecular alterations of this association.